CACNA1E and colorectal carcinoma: There is evidence, however, that nuclear βII can interact with antitumor drugs, such as paclitaxel and vinblastine [17,40,41], indicating that, if nuclear βII is indeed present in CRC and other tumors, then chemotherapeutic strategies may need to take this into account.